Eculizumab in the treatment of refractory idiopathic thrombotic thrombocytopenic purpura
John Chapin(NewYork–Presbyterian Hospital), Jeffrey Laurence(Cornell University), Cynthia M. Magro(Cornell University), Babette B. Weksler(Hospital for Special Surgery)
Cited by 99
Related Papers
Complement associated microvascular injury and thrombosis in the pathogenesis of severe COVID-19 infection: A report of five cases
|Translational research|2020|2.3k
Transforming growth factor-beta activity is potentiated by heparin via dissociation of the transforming growth factor-beta/alpha 2-macroglobulin inactive complex.
|The Journal of Cell Biology|1989|221
Academia Europaea Position Paper on Translational Medicine: The Cycle Model for Translating Scientific Results into Community Benefits
|Journal of Clinical Medicine|2020|209
Combination Chemotherapy of Advanced Diffuse Histiocytic Lymphoma with the Six-Drug COP-BLAM Regimen
|Annals of Internal Medicine|1982|188